Genes that alter risk represent origins of disease causation and are therefore involved in disease pathogenesis. Many strategies are now available to discover these genes. Candidate gene approaches have given way to reverse genetics as the genotyping capacity has very recently undergone a technical scientific revolution. We identified a convincing linkage at 12q24 in our Hispanic (HI) pedigrees multiplex for systemic lupus erythematosus (lupus or SLE) that we confirmed in our European-American (EA) pedigrees (1) and others confirmed with additional independent samples (2) (p=0.000000014). We screened the linkage support interval with 41 markers in promising candidate genes. Markers in three genes suggested association. Follow up case control studies in HI and EA show association in a transcription factor, with the best haplotype in this gene producing strong evidence for association, an effect that has been independently replicated (p=0.00002). The association remains significant after correction for all the tests actually performed (Bonnferroni) under the overly conservative assumption of marker independence (p=0.003). In Project #2, we will evaluate the genomics of the genetic association and carry these findings toward biological mechanism. We will more than double the sample size studied to date (>6600 HI and EA subjects) to improve power to discriminate the true genetic contributions. We will use currently accepted strategies to eliminate artifacts from sample population stratification. We will physically define the genomic interval containing the association effect. We will use sequencing and genotyping to characterize the possible contributing variants in the interval. We will construct haplotypes and apply standard regression methods to identify the primary association as well as any remaining residual independent associations. The candidate polymorphisms and their surrogates will be evaluated for genomic mechanism(s). Once a genomic model is developed, we will explore gene biology. When successfully completed this P01 project will provide one or more new genes with mechanistic insights into the mechanisms by which lupus is generated. At the same time the infrastructure developed through this P01 project will provide the basis from which to evaluate this and other compelling candidate genes important for lupus in Hispanics (HI). The enlarging sample size from the continuing efforts to expand the existing collections in Alabama and Oklahoma is critical to provide the statistical power with which to winnow the false positive genetic associations from those most likely to be true genetic associations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
5P01AR049084-07
Application #
7870368
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2009-05-01
Project End
2013-04-30
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
7
Fiscal Year
2009
Total Cost
$280,430
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :
Langefeld, Carl D; Ainsworth, Hannah C; Cunninghame Graham, Deborah S et al. (2017) Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 8:16021
Alarcón-Riquelme, Marta E; Ziegler, Julie T; Molineros, Julio et al. (2016) Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture. Arthritis Rheumatol 68:932-43
Lessard, Christopher J; Sajuthi, Satria; Zhao, Jian et al. (2016) Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans. Arthritis Rheumatol 68:1197-1209
Lu, Rufei; Munroe, Melissa E; Guthridge, Joel M et al. (2016) Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun 74:182-193
Zhao, Jian; Giles, Brendan M; Taylor, Rhonda L et al. (2016) Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis 75:242-52
Liu, Ke; Kurien, Biji T; Zimmerman, Sarah L et al. (2016) X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis Rheumatol 68:1290-1300
Taylor, Rhonda L; Cruickshank, Mark N; Karimi, Mahdad et al. (2016) Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells. Cell Mol Immunol 13:119-31
Deng, Yun; Zhao, Jian; Sakurai, Daisuke et al. (2016) Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Ann Rheum Dis 75:2007-2013
Lu, Xiaoming; Zoller, Erin E; Weirauch, Matthew T et al. (2015) Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. Am J Hum Genet 96:731-9

Showing the most recent 10 out of 215 publications